This discussion examines the key considerations oncologists weigh when choosing between chemotherapy alone or chemotherapy ...
Compounding Chemotherapy Market to Reach $6.3 Billion by 2027 in the short run and $9.8 Billion by 2034 Globally, at 6.4% CAGR: Allied Market Research ...
The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
The Brisbane Cancer Conference is a premier oncology meeting that brings together leading international researchers, clinicians and industry experts working in the fields of translational oncology, ...
A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of ...
Intermittent shortages of various injectable chemotherapy drugs have become a regular part of cancer care, with oncology practices reporting that despite their best efforts to mitigate supply ...
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and ...
Scientists from King's College London have successfully applied a new technology that disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs. The Efflux ...
Traditional chemotherapy drugs like 5-fluorouracil are poorly soluble, inefficient at reaching cancer cells, and cause severe side effects by damaging healthy tissue. In a promising advance for cancer ...
MONDAY, Oct. 27, 2025 (HealthDay News) — The most common cholesterol drug around might help protect cancer patients from “chemo brain.” Statins appeared to protect breast and lymphoma cancer patients’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback